2Greinachea A,volpel H,JanssensV, et al. Recombinant hirudin ( lepirudin) provides safe and effective anticoagulation in patzents with the immunologic type of heparin-induced thromboc ytopenia : a pros peetive study [J].Circulation. 1999.99( 1 ): 73.
3Greinachea A, JanssensV, Berg G,et al. lepirudin ( recumbinant hirdin) for parateral anticoagulation in patients zvlth hepar-ininduced thromboc ytopenia [J]. Circulation, 1999,100(6) : 587.
7Qrganization to Assess Strategies for lschemic Syndromes(OASIS) Investigators. Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischaemia without ST elevtion:a pilot study[J]. Circulation, 1997,96 (3) : 769.
8Greinachea A, lubenow N. Recombinant hirudin in clinical practice: focus on lepirudin [J]. Circulation, 2001,103 (10) :1479.
9Lee LV. Initial experience with hirudin and streptokinase in acute myocarction., results of the Thrombolysis in myocardial Infarction (TIMI) 6 trial[J]. Am J Cardiol,1995,75:7.
10Topol EJ, Fuster V,Harrington RA,et al. Recombinant hirudin for unstable angina pectoris: a multi center,randomized angiographic frial [J]. Circulation, 1994, 89:1557.